A double-blind trial of adjunctive allopurinol for schizophrenia
Authors:
- Faith B. DickersonFDFaith B. Dickerson
- Cassie R. StallingsCSCassie R. Stallings
- Andrea E. OrigoniAOAndrea E. Origoni
- Anne SullensASAnne Sullens
- Sunil KhushalaniSKSunil Khushalani
- Neil SandsonNSNeil Sandson
- Robert H. YolkenRYRobert H. Yolken
- 1 April 2009
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 109 (1-3) , 66-69
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosisThe Veterinary Journal, 2009
- Allopurinol as Adjuvant Therapy in Poorly Responsive or Treatment Refractory SchizophreniaAnnals of Pharmacotherapy, 2006
- Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implicationsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2006
- A Clinical Trial of Adjuvant Allopurinol Therapy for Moderately Refractory SchizophreniaThe Journal of Clinical Psychiatry, 2005
- Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2005
- Cetirizine and allopurinol as novel weapons against cellular autoimmune disordersInternational Immunopharmacology, 2004
- The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003Schizophrenia Bulletin, 2004
- Pharmacology of Drugs for Hyperuricemia2004
- Allopurinol augmentation for poorly responsive schizophreniaInternational Clinical Psychopharmacology, 2001
- Allopurinol for refractory aggression and self-inflicted behaviourJournal of Psychopharmacology, 2000